No Data
No Data
No Data
No Data
No Data
Improved Revenues Required Before Baxter International Inc. (NYSE:BAX) Shares Find Their Feet
You may think that with a price-to-sales (or "P/S") ratio of 1.4x Baxter International Inc. (NYSE:BAX) is a stock worth checking out, seeing as almost half of all the Medical Equipment companies in th
Simply Wall StApr 20 22:16
Non-Hodgkin Lymphoma Therapeutics Market Size Is Set to Grow by USD 5.42 Billion From 2023-2027, AstraZeneca Plc, Baxter International Inc. and Bayer AG, and More to Emerge as Some of the Key Vendors, Technavio
The global non-hodgkin lymphoma therapeutics market size is estimated to grow by USD 5427.51 mn from 2023 to 2027, according to Technavio. The market ...
PR NewswireApr 17 05:25
Baxter's (BAX) New Injectables Aid Its Pharmaceutical Portfolio
Yahoo FinanceApr 12 23:00
Comfort Systems USA and Boeing Have Been Highlighted as Zacks Bull and Bear of the Day
Yahoo FinanceApr 12 20:29
Baxter Expands Pharmaceuticals Portfolio With Five Injectable Products In U.S.
Five new launches reinforce Baxter's focus on differentiated products and enhance the company's Pharmaceuticals portfolio in critical therapeutic areasProducts feature ready-to-use formulations to hel
BenzingaApr 11 20:32
Baxter Expands Pharmaceuticals Portfolio With New Injectable Products in the U.S.
Baxter International Inc. (NYSE:BAX), a global leader in injectables, anesthesia and drug compounding, announced the continued expansion of its Pharmaceuticals portfolio with five injectable product launches in the U.S.
BusinesswireApr 11 20:30
No Data
No Data